4 documents found, page 1 of 1
Comparing international guidelines for the remission of hypertension after bari...
Dias, Carina Vieira; Silva, Ana Lúcia; Dias, Joana; Cardoso, paulo; Castanheira, Rute; Fernandes, Andreia; Nunes, Filipa; Sanai, Tina; Sanchez, MercedesBackground/Objectives: Obesity remains a global health concern and is associated with an increased risk of type 2 diabetes, hypertension, and cardiovascular disease overall. Dissimilar hypertension guidelines are available for clinicians, namely those prepared by the American Heart Association (AHA) and the European Society of Cardiology (ESC), which may lead to a distinctive appreciation of health outcomes of ...
Comparing international guidelines for the remission of hypertension after bari...
Dias, Carina Vieira; Silva, Ana Lúcia; Dias, Joana; Cardoso, Paulo; Castanheira, Rute; Fernandes, Andreia; Nunes, Filipa; Sanai, Tina; Sanchez, MercedesBackground/Objectives: Obesity remains a global health concern and is associated with increased risk of type 2 diabetes, hypertension, and cardiovascular disease overall. Dissimilar hypertension guidelines are available for clinicians, namely those prepared by the American Heart Association (AHA) and the European Society of Cardiology (ESC), which may lead to distinctive appreciation of health outcomes of patie...
Remission of polypharmacy in patients with diabetes after obesity surgery
Dias, Joana; Cardoso, Paulo; Sanchez, Mercedes; Maia-Teixeira, João; De Sousa-Coelho, Ana LuísaIntroduction: Obesity contributes to increased risk of developing comorbidities that require polypharmacy (taking ≥5 medicines) [1], namely type 2 diabetes (T2D) [2], increasing the risk of drug-related problems. Bariatric surgery (BS) has emerged as the most effective treatment for obesity and T2D remission [3–5]. Objective: The goal of this study was to evaluate the impact of BS in the remission of polypharma...
AHA vs ESC guidelines at the race for hypertension remission after obesity surg...
Dias, Carina; Dias, Joana; Silva, Ana Lúcia; Cardoso, Paulo; Castanheira, Rute; Sanchez, Mercedes; Maia-Teixeira, João; De Sousa-Coelho, Ana LuísaBackground: Obesity is associated with increased risk of hypertension. Dissimilar hypertension guidelines are available for clinicians, namely prepared by the American Heart Association (AHA) and the European Society of Cardiology (ESC) [1,2]. While AHA guidelines consider pharmacological treatment to all patients when blood pressure (BP) values ≥140/90 mmHg, ESC recommends it that only consider pharmacological...